M39 Obesity Medications

Program: Meet-the-Professor Sessions
Clinical Session
Sunday, April 3, 2016: 10:00 AM-10:45 AM
Room 253 (BCEC)
Sunday, April 3, 2016: 2:15 PM-3:00 PM
Room 253 (BCEC)
Speaker:
Louis J Aronne, MD, FACP, Weill Cornell Medical College, New York, NY

Disclosures:
LJA: Researcher, Eisai, Scientific Board Member, Pfizer, Inc., Scientific Board Member, Novo Nordisk, Scientific Board Member, GI Dynamics, Scientific Board Member, Jovia Health, Board Member, Jamieson Labs, Scientific Board Member, Zafgen, Scientific Board Member, Gelesis, Board Member, MYOS Corp, Researcher, Aspire Bariatric.

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire